What Washington, D.C. could learn from Washington State on health reform
The story of 1993 Washington Health Services Act should serve as a cautionary tale.
The story of 1993 Washington Health Services Act should serve as a cautionary tale.
FDA shouldn’t cave to pressure and allow Genentech to keep advanced metastatic breast cancer on the Avastin label, argues Merrill Goozner.
Jon Cohn answers John Goodman’s column: Comparing Medicaid cutbacks to private insurer’s dropping costly patients “is grossly misleading,” Cohn writes.
By any measure, the true cost of the health care legislation is well over $1 trillion for the first ten years and in no way will it reduce the deficit.
In healthcare, in areas where patients pay out of pocket for services entrepreneurs, driven by market forces, have been lowering cost and raising quality.
Jon Cohn argues that news stories about businesses dropping insurance and insurers limiting doctor choice isn’t bad: they highlight health reform’s benefits.
Clinical trials that compare effectiveness–and safety–of new drugs with old drugs would not only save lives, but money as well, says Merrill Goozner
Add it all up and the budget deficit actually gets a little smaller. The emphasis is on “little,” since the net reduction is actually pretty small.
“Will most people’s health insurance still change? Absolutely. But change was coming no matter what. With reform, it’s likely to be change for the better,” writes Jon Cohn.
Did industry influence prompt WHO to change its working definition of pandemic, asks Seattle global health blogger Tom Paulson.
Maybe someone should take a hard look at how many members of the G8 kept their previous global health commitments — and whether these new commitments represent true progress or sort of a shell game.
Seattle global health blogger Tom Paulson asks: Have women and children’s health issues really been neglected in global health policy and agenda-setting? And if so, how?
The question isn’t so much whether the waste exists. The question, rather, is whether reform can pinpoint and excise that waste — whether it can cut out the bad medical care without removing the good.
Seattle global health blogger Tom Paulson covers a talk by Dr. Jonathan Fine, a leading physician activist, on the inequities of development in India.
UW study shows drug treatment cuts HIV transmission 92%. Some experts say the spread of AIDS in Africa could be contained in as little as five years if everyone infected received treatment now.
Worldwide, child mortality is down, but the U.S. does far worse than most of the rest of the developed world, writes Seattle global health reporter Tom Paulson
Tom Paulson went to Thailand believing the recent AIDS vaccine trial had been a success; when he got there he learned about some serious, unresolved problems.
Few noticed that a flurry of grant awards given out this week from the Gates Foundation signaled a shift in this direction, writes Seattle global health blogger Tom Paulson
More needs to be done to guarantee that drugs in the developing world are safe and effective, writes Seattle global health blogger Tom Paulson
Seattle Global Health Blogger Tom Paulson casts his skeptical eye on two recent articles on global health funding.
A lot of people laughed when Sue Lowden, the Nevada Republican running for the U.S. Senate, suggested last month that people start paying for their medical care with chickens. I didn’t.
Michigan’s attorney general wants the new health reform law overturned. Jon Cohn reviews what the state’s residents will lose should their attorney general succeed.
Each time lawmakers adopt a new mandate, proponents predict the change will increase the affordability and accessibility of care, but research shows the opposite has happened, Guppy argues.
After three years, no real progress has been made on rising costs. The program remains well over budget, with no end in sight.
“From now on, the federal government will manage the health care of all Washingtonians.”
There are two ways for societies to decide how to allocate resources: collectively, through government, or individually, through the market.
Will reform pay for itself? The answer will come slowly over the next decade as the reforms gradually go into effect.
The evolution of Blue Cross is a case study in the need for health care reform.
The key is finding a fix that helps both doctors and the patients, rather than one at the expense of the other.
A 1983 bill cut billions of dollars from the federal budget, caused medical inflation to plummet, yet still maintained quality.